Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Status:
Terminated
Trial end date:
2016-05-20
Target enrollment:
Participant gender:
Summary
The purpose of this multi-center, randomized, double-blind, parallel-group, 26 week study is
to compare the efficacy and safety of two different dose levels of Amantadine Extended
Release Tablets to placebo for the treatment of levodopa induced dyskinesia in patients with
Parkinson's disease.